Hoersholm, 2016-08-30 16:19 CEST (GLOBE NEWSWIRE) --
Company announcement No. 12 / 2016
2016
26 October Annual Report 2015/16
29 November Annual General Meeting
Please note that proposals which shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday, 17 October 2016.
2017
11 January Interim Report (Q1 2016/17)
6 April Interim Report (Q2 2016/17)
29 June Interim Report (Q3 2016/17)
25 October Annual Report 2016/17
28 November Annual General Meeting
Please note that proposals which shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday, 16 October 2017.
For further information, please contact:
Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618
The announcement has been prepared in Danish and in English. In the event of discrepancies, the Danish version prevails.
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2014/15 financial year was EUR 859 million. The company has more than 2,600 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.
